StockpollyBeta
Get App
Popularity #1,634
RCUS · NYSE · Biotechnology

Arcus Biosciences (RCUS)

Develops small-molecule and antibody therapies for cancer and inflammatory diseases.

$25.91
vs last close−0.96 (−3.57%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue32311453948262816026331741
Cost of revenue000000002320
Gross profit32311453948262816024301541
112122161145153129150168166144149137
Research & development8293109115123101122139141121122113
302932303028282927262924
General & administrative302932303028282927262924
Other expenses002000000−2−3−20
Operating income−80−91−16−106−105−103−122−8−142−114−134−96
1111121313910071665
Interest income1211131314121110103198
Interest expense1010121231433
Other non-operating income−12−11−13−13−14−11−11−10−10−30−9−8
Income before tax−69−80−4−93−92−94−112−8−135−98−128−91
Income tax expense210001000000
Net income from continuing operations−71−81−4−93−92−95−112−8−135−98−128−91
Other adjustments000001000000
Net income−71−81−4−93−92−94−112−8−135−98−128−91
EPS, basic−$0.95−$1.08−$0.05−$1.02−$1.01−$1.03−$1.14−$0.08−$1.27−$0.92−$1.02−$0.72
EPS, diluted−$0.95−$1.08−$0.05−$1.02−$1.01−$1.03−$1.14−$0.08−$1.27−$0.92−$1.02−$0.72
Weighted average shares, basic75758691919298106107107125126
Weighted average shares, diluted75758691919298107107107125126
EBITDA−67−770−91−89−89−1084−130−81−123−85
Depreciation & amortization133223322323
EBIT−68−80−3−93−91−92−1112−132−84−125−88